Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00306085
Status:
UNKNOWN
Last Update Posted:
2006-03-22
First Post:
2006-03-14
Brief Title:
Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis
Sponsor:
University of Naples
Organization:
University of Naples
Study Overview
Official Title:
Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis
Status:
UNKNOWN
Status Verified Date:
2006-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Implantation of bone marrow cells including endothelial progenitor cells into ischemic limbs has been shown to improve collateral vessel formation In the present study the safety and feasibility of autologous blood mononuclear cells implantation will be investigated in patients with severe peripheral atherosclerosisTwenty cases will be enrolled Improvement in the ankle-brachial pressure index ABI01 ischemic ulcers and angiography as well as laser doppler flow will be evaluated until six months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None